In The Press February 07, 2021

Not So Different: The Race To The Top: Does China Have What It Takes? (The Center for Biosimilars)

The biosimilar market in China has some similarities to the one in the United States. Still, there are some major differences. First, to get a biosimilar developed and approved takes much longer in the US than in China. According to Huiya Wu, JD, an intellectual property lawyer from Goodwin, biosimilar development alone takes around 7 to 8 years in the US but could take as little as 5 years in China. Read The Center for Biosimilars article here.